Patient-Perceived Outcomes and Quality of Life in ALS

Neurotherapeutics

Volumn 12, Issue 2, 2015, Pages 394-402

  Simmons, Zachary ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Health related quality of life; Outcome measures; Psychological health; Quality of life

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; AWARENESS; CLINICAL TRIAL (TOPIC); HUMAN; OUTCOME ASSESSMENT; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE;

AMYOTROPHIC LATERAL SCLEROSIS; AWARENESS; CLINICAL TRIALS AS TOPIC; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 84939966378     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-014-0322-x     Document Type: Article

References (92)

1. ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Arch Neurol 1996;53:141–147.
2. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13–21.
3. Lanka V, Cudkowicz M. Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler 2008;9:131–141.
4. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461–472.
5. Ward MM. Clinical measures in rheumatoid arthritis: Which are most useful in assessing patients? J Rheumatol 1993;21:17–21.
6. Ruhland J, Shields R. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 1997;77:1026–1039.
7. Wang B, Gladman D, Urowitz M. Fatigue in lupus is not correlated with disease activity. J Rheumatol 1998;25:892–895.
8. Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585–591.
9. Lacomblez L, Bensimon G, Leign PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996;347:1425–1431.
10. McElhiney M, Rabkin JG, Goetz R, et al. Seeking a measure of clinically meaningful change in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:398–405.
11. Simmons Z. Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 2005;11:257–270.
12. Simmons Z. Rehabilitation of motor neuron disease. In: Barnes M, Good D, eds. Neurorehabilitation. Handbook of Clinical Neurology (Michael Aminoff, series ed). Elsevier, Amsterdam, 2013;483–498.
13. Slevin ML, Plant H, Lynch D, et al. Who should measure the quality of life, the doctor or the patient? Br J Cancer 1988;57:109–112.
14. Gerhart KA, Koziol-McLain J, Lowenstein SR, et al. Quality of life following spinal cord injury: knowledge and attitudes of emergency care providers. Ann Emerg Med 1994;23:807–812.
15. Rothwell PM, McDowell Z, Wong CK, et al. Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580–1583.
16. Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003;209:79–85.
17. Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005;19:182–193.
18. Lule D, Ehlich B, Lang D, et al. Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol 2013;260:2836–2843.
19. Adelman EE, Albert SM, Rabkin JG, et al. Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology 2004;62:1766–1770.
20. Olsson AG, Markhede I, Strang S, Persson LI. Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time. Acta Neurol Scand 2010;121:244–250.
21. WHOQOL: Measuring Quality of Life. Geneva: World Health Organization; 1997.
22. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619–626.
23. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787–805.
24. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992;30:473–483.
25. McGuire D, Garrison L, Armon C, et al. Relationship of the Tufts Quantitative Neuromuscular Examination (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. Neurology 1996;46:1442–1444.
26. Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med 2004;7:551–557.
27. Kiebert GM, Green C, Murphy C, et al. Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci 2001;191:87–93.
28. Jenkinson C, Fitzpatrick R. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry 2001;70:70–73.
29. Green C, Kiebert G, Murphy C, et al. Patients’ health-related quality-of-life and health state values for motor neuron disease/amyotrophic lateral sclerosis. Qual Life Res 2003;12:565–574.
30. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46 (12):1569–1585.
31. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551–558.
32. Skevington SM, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the QHOQOL group. Qual Life Res 2004;13:299–310.
33. Cohen SR, Hassan SA, Lapointe BJ, Mount BM. Quality of life in HIV disease as measured by the McGill Quality of Life questionnaire. AIDS 1996;10:1421–1427.
34. Cohen SR, Mount BM, Tomas JJN, Mount LF. Existential well-being is an important determinant of quality of life. Cancer 1996;77:576–586.
35. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K. Validity of the McGill Quality of Life questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 1997;11:3–20.
36. Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000;55:388–392.
37. Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of Life in ALS is maintained as physical function declines. Neurology 2001;56:442–444.
38. Walsh SM, Bremer BA, Felgoise SH, Simmons Z. Religiousness is related to quality of life in patients with ALS. Neurology 2003;60:1527–1529.
39. Bremer BA, Simone A-L, Walsh S, Simmons Z, Felgoise SH. Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self- perception and religiosity, Ann Behav Med 2004;28:119–125.
40. McGee HM, O’Boyle CA, Hickey A, Joyce CRB, O’Malley K. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991;21:749–759.
41. Hickey AM, Bury G, O’Boyle CA, Bradley F, O’Reilly F, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. Br Med J 1996;313:29–33.
42. Hickey A, O’Boyle CA, McGee HM, Joyce CRB. The schedule for the evaluation of individual quality of life. In: Joyce CRB, McGee HM, O’Boyle CA, eds. Individual Quality of Life: Approaches to Conceptualisation and Assessment. Harwood Academic Publishers, The Netherlands, 1999, pp 119–133.
43. Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomized study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191:103–109.
44. Bromberg MB, Forshew DA. Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002;58:320–322.
45. Goldstein LH, Atkins L, Leigh PN. Correlates of quality of life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3:123–129.
46. Felgoise SH, Stewart JL, Bremer BA, Walsh SM, Bromberg MB, Simmons Z. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations. Amyotroph Lateral Scler 2009;10:456–462.
47. Simmons Z, Felgoise SH, Bremer BA, et al. The ALSSQOL: balancing physical and non-physical factors in assessing quality of life in ALS. Neurology 2006;67:1659–1664.
48. Simmons Z, Felgoise SH, Rodriguez JL, Walsh SM, Bremer BA, Stephens HE. Validation of a shorter ALS-specific quality of life instrument: the ALSSQOL-R. Neurology 2010;74 (suppl 2):A177-A178.
49. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality of life research. Soc Sci Med 1999;48:1531–1548.
50. Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? Br Med J 2001;322:1240–1243.
51. Barclay R, Tate RB. Response shift recalibration and reprioritization in health-related quality of life was identified prospectively in older men with and without stroke. J Clin Epidemiol 2014;67:500–507.
52. Abramson N. Quality of life: who can make the judgment? Am J Med 1996;100:365–366.
53. McDonald ER, Hillel A, Wiedenfeld SA. Evaluation of the psychological status of ventilator-supported patients with ALS/MND. Palliat Med 1996;10:35–41.
54. Rousseau MC, Pietra S, Blaya J, Catala A. Quality of life of ALS and LIS patients with and without invasive mechanical ventilation. J Neurol 2011;258:1801–1804.
55. Vianello A, Arcaro G, Palmieri A, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care 2011;26:329 e7-14.
56. Kaub-Wittemer D, von Steinbuchel N, Wasner M, et al. Quality of life and pychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage 2003;26:890–896.
57. Rabkin JG, Albert SM, Del Bene ML, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005;65:62–67.
58. Wicks P, Abrahams S, Masia D, Hejda-Fordea S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol 2007; 14:993–1001.
59. McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 2009;80:1146–1149.
60. Cupp J, Simmons Z, Berg A, Felgoise SH, Walsh SM, Stephens HE. Psychological health in patients with ALS is maintained as physical function declines. Amyotroph Lateral Scler 2011;12:290–296.
61. Felgoise SH, Chakraborty BH, Bond E, et al. Psychological morbidity in ALS: the importance of psychological assessment beyond depression alone. Amyotroph Lateral Scler 2010;11:351–358.
62. Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med 1998;339:967–973.
63. Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. J Neurol Sci 1998;160 (suppl 1): S53-S56. ;
64. Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000;62:271–279.
65. Lou J-S, Reeves A, Benice T, et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003;60: 122–123.
66. Averill AJ, Kasarskis EJ, Severstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:243–254
67. Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999;52:1434–1440.
68. Gauthier A, Vignola A, Calvo A, et al. A longitudinal study of qualify of life and depression in ALS patient-caregiver couples. Neurology 2007;68:923–926.
69. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients. J Chron Dis 1981;34:585–597.
70. Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol 2013;28:115–119.
71. Minkoff K, Bergman E, Beck AT, et al. Hopelessness, depression, and attempted suicide. Am J Psychiatry 1973;130:455–459.
72. Beck AT, Brown G, Berchick RJ, et al. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990;147: 190–195.
73. Ganzini L, Silveira MJ, Johnston WS. Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington. J Pain Symptom Manage 2002;24:312–317.
74. Vignola A, Guzzo A, Calvo A, et al. Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol 2008;15:1231–1236.
75. Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess 1985;49:71–75.
76. Pagnini F, Simmons Z, Corbo M, Molinari E. Amyotrophic lateral sclerosis: time for research on psychological interventions? Amyotroph Lateral Scler 2012;13:416–417.
77. McHorney C, Robbins J, Lomax K, et al.: The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia 2002;17:97–114
78. Paris G, Martinaud O, Petit A, et al. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life. J Oral Rehabil 2013;40:199–204.
79. Chio A, Canosa A, Gallo S, et al. Pain in amyotrophic lateral sclerosis: a population-based study. Eur J Neurol 2013;19:551–555.
80. Pagnini F, Lunetta C, Banfi P, et al. Pain in amyotrophic lateral sclerosis: a psychological perspective. Neurol Sci 2012;33:1193–1196.
81. Colamonico J, Formella A, Bradley W. Pseudobulbar affect: burden of illness in the USA. Adv Ther 2012;29:775–798.
82. Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65:1264–1267.
83. Korner S, Siniawski M, Kollewe K, et al. Speech therapy and communication device: impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:20–25.
84. Montel S, Albertini L, Spitz E. Coping strategies in relation to quality of life in amyotrophic lateral sclerosis. Muscle Nerve 2012;45:131–134.
85. Jackson CE, Rosenfeld J, Moore DH, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75–78.
86. Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with non-invasive ventilation. Neurology 2001;57:153–156.
87. Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Non-invasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;61:171–177.
88. Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, et al. Longitudinal effects of non-invasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2003;82:597–604.
89. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol 2006;5:140–147
90. Zamietra K, Lehman EB, Felgoise SH, Walsh SM, Stephens HE, Simmons, Z. Noninvasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotroph Lateral Scler 2012;13:55–58.
91. Korner S, Hendricks M, Kollewe K, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurology 2013;13:84.
92. Gibbons C, Thornton E, Ealing, J, et al. The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemp Degener 2013;14:537–545.